Search Results - Francesca Gasperoni
- Showing 1 - 2 results of 2
-
1
Optimal risk assessment intervals for primary prevention of cardiovascular disease: a population-based two-stage landmarking study by Angela M Wood, Katrina Poppe, Emanuele Di Angelantonio, David Stevens, Ellie Paige, Juliet Usher-Smith, Michael Sweeting, Matthew Arnold, Zander Gu, Francesca Gasperoni, Jessica K Barrett
Published in BMJ Public Health (2025-05-01)Get full text
Article -
2
A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort by Michela Carlotta Massi, Michela Carlotta Massi, Francesca Gasperoni, Francesca Ieva, Francesca Ieva, Francesca Ieva, Anna Maria Paganoni, Anna Maria Paganoni, Anna Maria Paganoni, Paolo Zunino, Andrea Manzoni, Nicola Rares Franco, Liv Veldeman, Liv Veldeman, Piet Ost, Piet Ost, Valérie Fonteyne, Valérie Fonteyne, Christopher J. Talbot, Tim Rattay, Adam Webb, Paul R. Symonds, Kerstie Johnson, Maarten Lambrecht, Karin Haustermans, Gert De Meerleer, Dirk de Ruysscher, Dirk de Ruysscher, Ben Vanneste, Evert Van Limbergen, Evert Van Limbergen, Ananya Choudhury, Rebecca M. Elliott, Elena Sperk, Carsten Herskind, Marlon R. Veldwijk, Barbara Avuzzi, Tommaso Giandini, Riccardo Valdagni, Riccardo Valdagni, Riccardo Valdagni, Alessandro Cicchetti, David Azria, Marie-Pierre Farcy Jacquet, Barry S. Rosenstein, Barry S. Rosenstein, Richard G. Stock, Kayla Collado, Ana Vega, Ana Vega, Ana Vega, Miguel Elías Aguado-Barrera, Miguel Elías Aguado-Barrera, Patricia Calvo, Patricia Calvo, Alison M. Dunning, Laura Fachal, Laura Fachal, Sarah L. Kerns, Debbie Payne, Jenny Chang-Claude, Jenny Chang-Claude, Petra Seibold, Catharine M. L. West, Tiziana Rancati
Published in Frontiers in Oncology (2020-10-01)Get full text
Article
